T. Rowe Price Associates
NVRO

T. Rowe Price Associates’s NEVRO CORP. NVRO Stock Holding History

T. Rowe Price Associates’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-140,015
Closed -$818K – 3181
2025
Q1 		$818K Buy
140,015
+775
+0.6% +$4.08K ﹤0.01% 2055
2024
Q4 		$518K Buy
139,240
+38,869
+39% +$179K ﹤0.01% 2267
2024
Q3 		$562K Buy
100,371
+44,716
+80% +$313K ﹤0.01% 2202
2024
Q2 		$469K Buy
55,655
+10,639
+24% +$113K ﹤0.01% 2216
2024
Q1 		$651K Buy
45,016
+7,004
+18% +$116K ﹤0.01% 2101
2023
Q4 		$819K Buy
38,012
+1,583
+4% +$28.2K ﹤0.01% 1965
2023
Q3 		$701K Sell
36,429
-397,128
-92% -$8.47M ﹤0.01% 1959
2023
Q2 		$11M Buy
433,557
+71,228
+20% +$2.06M ﹤0.01% 1062
2023
Q1 		$13.1M Buy
362,329
+81,895
+29% +$2.88M ﹤0.01% 1010
2022
Q4 		$11.1M Sell
280,434
-10,099
-3% -$420K ﹤0.01% 1034
2022
Q3 		$13.5M Sell
290,533
-728,899
-72% -$33.8M ﹤0.01% 1008
2022
Q2 		$44.7M Sell
1,019,432
-2,073,827
-67% -$114M 0.01% 910
2022
Q1 		$224M Buy
3,093,259
+764,728
+33% +$55.1M 0.02% 500
2021
Q4 		$189M Sell
2,328,531
-2,343,234
-50% -$235M 0.02% 571
2021
Q3 		$544M Buy
4,671,765
+226
+0% +$29.6K 0.05% 333
2021
Q2 		$774M Sell
4,671,539
-23,165
-0.5% -$3.62M 0.07% 270
2021
Q1 		$655M Buy
4,694,704
+666,384
+17% +$109M 0.07% 292
2020
Q4 		$697M Sell
4,028,320
-535,455
-12% -$86.7M 0.07% 270
2020
Q3 		$636M Sell
4,563,775
-331,433
-7% -$44.3M 0.07% 271
2020
Q2 		$585M Buy
4,895,208
+231,723
+5% +$27.5M 0.07% 271
2020
Q1 		$466M Buy
4,663,485
+1,980,647
+74% +$238M 0.07% 269
2019
Q4 		$315M Sell
2,682,838
-723,976
-21% -$71.7M 0.04% 380
2019
Q3 		$293M Buy
3,406,814
+328,179
+11% +$24.8M 0.04% 372
2019
Q2 		$200M Buy
3,078,635
+1,470,807
+91% +$91.6M 0.03% 466
2019
Q1 		$101M Buy
1,607,828
+620,562
+63% +$29.2M 0.01% 634
2018
Q4 		$38.4M Buy
987,266
+141,740
+17% +$6.3M 0.01% 918
2018
Q3 		$48.2M Buy
845,526
+825,678
+4,160% +$51.6M 0.01% 924
2018
Q2 		$1.58M Buy
19,848
+6,136
+45% +$509K ﹤0.01% 1655
2018
Q1 		$1.19M Sell
13,712
-34,841
-72% -$2.81M ﹤0.01% 1720
2017
Q4 		$3.35M Buy
48,553
+36,595
+306% +$2.93M ﹤0.01% 1480
2017
Q3 		$1.09M Sell
11,958
-2,520
-17% -$216K ﹤0.01% 1779
2017
Q2 		$1.08M Buy
14,478
+3,121
+27% +$250K ﹤0.01% 1752
2017
Q1 		$1.06M Sell
11,357
-76,940
-87% -$6.97M ﹤0.01% 1770
2016
Q4 		$6.42M Buy
88,297
+25,620
+41% +$2.19M ﹤0.01% 1386
2016
Q3 		$6.54M Buy
+62,677
New +$5.66M ﹤0.01% 1390
2015
Q1 		– Sell
-349,200
Closed -$13.5M – 2576
2014
Q4 		$13.5M Buy
+349,200
New +$11M ﹤0.01% 1241

Other funds holding NVRO

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

T. Rowe Price Associates's NVRO Position: Q2 2025 in Review

T. Rowe Price Associates sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 140,015 shares — an estimated $818K sold.

T. Rowe Price Associates first reported a position in NVRO in Q4 2014 and held it in 36 quarters. The position peaked at $774M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • T. Rowe Price Associates reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 140,015 NEVRO CORP. shares in Q2 2025, an estimated $818K.
  • T. Rowe Price Associates first reported a position in NEVRO CORP. in Q4 2014 and held it in 36 quarters.
  • T. Rowe Price Associates's NEVRO CORP. position peaked at $774M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.